Prothena: 2Q Earnings Snapshot

·1 min read

DUBLIN (AP) _ Prothena Corp. (PRTA) on Thursday reported a loss of $26.3 million in its second quarter.

On a per-share basis, the Dublin-based company said it had a loss of 66 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.

The drug developer posted revenue of $195,000 in the period.

Prothena shares have dropped 18% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.91, a climb of 40% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PRTA at